About DS Healthcare Group (OTCMKTS:DSKX)
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.
Industry, Sector and Symbol
Industry Toilet preparations
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$12.95 million
Price / Sales0.00
Price / CashN/A
Book Value$0.05 per share
Price / Book0.02
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
DS Healthcare Group (OTCMKTS:DSKX) Frequently Asked Questions
What is DS Healthcare Group's stock symbol?
DS Healthcare Group trades on the OTCMKTS under the ticker symbol "DSKX."
Who are some of DS Healthcare Group's key competitors?
Some companies that are related to DS Healthcare Group include Cache (CACH), G-Estate Liquidation Stores (GMANQ), diaDexus (DDXS), ITT Educational Services (ESINQ), NephroGenex (NRXGQ), Kid Brands (KIDB), School Specialty (SCHSQ), Local (LOCMQ), Body Central (BODY), Alco Stores (ALCSQ), Shale Oil International (SHLE), New Western Energy (NWTR), Circle Star Energy (CRCL), CTPartners Executive (CTPR), Alexza Pharmaceuticals (ALXA), Altice S A (ATCEY), AMS (AMSSY) and ATP Oil & Gas (ATPAQ).
Who are DS Healthcare Group's key executives?
DS Healthcare Group's management team includes the folowing people:
- Myron Lewis, Chairman of the Board
- Robert Bellaflores, Chief Financial Officer, Vice President, Controller, Director
- Manuel Gonzalez, Chief Commercial Officer
- Justina Ng Lian Ping, Director
Has DS Healthcare Group been receiving favorable news coverage?
Media coverage about DSKX stock has trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm scores the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. DS Healthcare Group earned a daily sentiment score of 0.18 on Accern's scale. They also assigned news coverage about the specialty retailer an impact score of 44.45 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of DS Healthcare Group?
Shares of DSKX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is DS Healthcare Group's stock price today?
One share of DSKX stock can currently be purchased for approximately $0.0010.
How big of a company is DS Healthcare Group?
DS Healthcare Group has a market capitalization of $30,000.00 and generates $12.95 million in revenue each year. DS Healthcare Group employs 131 workers across the globe.
How can I contact DS Healthcare Group?
DS Healthcare Group's mailing address is 1601 GREEN ROAD, DEERFIELD BEACH FL, 33064. The specialty retailer can be reached via phone at 888-404-7770 or via email at [email protected]
MarketBeat Community Rating for DS Healthcare Group (DSKX)MarketBeat's community ratings are surveys of what our community members think about DS Healthcare Group and other stocks. Vote "Outperform" if you believe DSKX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DSKX will underperform the S&P 500 over the long term. You may vote once every thirty days.
DS Healthcare Group (OTCMKTS:DSKX) Analyst Ratings History
(Data available from 4/23/2016 forward)
DS Healthcare Group (OTCMKTS:DSKX) Earnings History and Estimates Chart
DS Healthcare Group (OTCMKTS DSKX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/14/2017||Q2 2017||($0.10)||$2.23 million||View||N/A|
|5/15/2017||Q1 2017||($0.05)||$2.09 million||View||N/A|
|3/31/2017||Q4 2016||($0.08)||$3.10 million||View||N/A|
|11/9/2016||Q3 2016||($0.05)||$2.68 million||View||N/A|
|10/7/2016||Q4 2015||($0.56)||$1.68 million||View||N/A|
|11/17/2015||Q3 2015||($0.03)||$3.73 million||$3.64 million||View||N/A|
|5/20/2015||Q1 2015||($0.01)||$2.80 million||View||N/A|
|4/15/2015||Q4 2014||$0.02||$3.71 million||View||N/A|
|8/15/2014||Q2 2014||($0.04)||$3.74 million||View||N/A|
|5/15/2014||Q1 2014||($0.05)||$2.69 million||View||N/A|
|4/4/2014||Q4 2013||($0.07)||$3.06 million||View||N/A|
|11/15/2013||Q3 2013||($0.08)||$3.20 million||View||N/A|
|8/20/2013||Q2 2013||($0.06)||$3.43 million||View||N/A|
|5/16/2013||Q1 2013||($0.04)||$3.97 million||View||N/A|
DS Healthcare Group (OTCMKTS:DSKX) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
DS Healthcare Group (OTCMKTS DSKX) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 19.40%
Institutional Ownership Percentage: 0.01%
DS Healthcare Group (OTCMKTS DSKX) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|7/17/2017||Yasuhiro Fujiwara||CEO||Buy||2,500,000||$0.10||$250,000.00||2,815,000|| |
|6/25/2015||Daniel Khesin||CEO||Buy||3,000||$3.25||$9,750.00|| |
|6/23/2015||Daniel Khesin||CEO||Buy||2,225||$4.51||$10,034.75|| |
|6/18/2015||Mark Edward Wolfson||Director||Sell||27,650||$4.28||$118,342.00|| |
|6/15/2015||Daniel Khesin||CEO||Buy||3,500||$3.71||$12,985.00|| |
|5/21/2015||Daniel Khesin||CEO||Buy||1,000||$2.07||$2,070.00|| |
|11/17/2014||Daniel Khesin||CEO||Buy||1,000||$0.80||$800.00|| |
|11/7/2014||Daniel Khesin||CEO||Buy||1,000||$0.85||$850.00|| |
|9/10/2014||Daniel Khesin||CEO||Buy||1,000||$1.09||$1,090.00|| |
|9/10/2014||Mark Edward Wolfson||Director||Buy||2,389||$1.09||$2,604.01|| |
|8/22/2014||Mark Edward Wolfson||Director||Buy||2,650||$1.10||$2,915.00|| |
|7/17/2014||Daniel Khesin||CEO||Buy||1,000||$1.40||$1,400.00|| |
|7/15/2014||Daniel Khesin||CEO||Buy||1,000||$1.43||$1,430.00|| |
|1/17/2014||Michael Strong||Major Shareholder||Sell||12,465||$2.50||$31,162.50|| |
DS Healthcare Group (OTCMKTS DSKX) News Headlines
DS Healthcare Group (OTCMKTS:DSKX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
DS Healthcare Group (OTCMKTS:DSKX) Income Statement, Balance Sheet and Cash Flow Statement
DS Healthcare Group (OTCMKTS DSKX) Stock Chart for Monday, April, 23, 2018